Neurotech founder Adrian Trevisan (left) with chief executive Wolfgang Storf.

Neurotech makes solid ASX debut

A neuroscience-focused business that has been backed by the Perth-based Trevisan family has made a solid debut on the ASX after completing a $7 million initial public offering led by Azure Capital.


(existing subscribers)

The password field is case sensitive.
Request new password

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Total Shareholder Return as at 31/03/20

1 year TSR5 year TSR
635thOakajee Corporation-56%-3%
704thAltech Chemicals-66%-9%
723rdNeurotech International-68%
761stProtean Energy-75%-61%
669 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

$0 Issued
$0 Issued
$0 Issued
Total value as at the date of the transaction
Powered by Morningstar ®


161st↑Neurotech International$246k
188th↑Altech Chemicals$0
191st-Oakajee Corporation$0
192nd↑Protean Energy$0
198 listed industrial companies ranked by revenue.
Powered by Morningstar ®